Gilead Sciences (GILD) Long-Term Deferred Tax (2009 - 2026)

Gilead Sciences (GILD) has 12 years of Long-Term Deferred Tax data on file, last reported at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 31.3% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (down 31.3% YoY), and the FY2025 full-year result was $2.0 billion, down 17.41% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $1.8 billion, down from $2.0 billion in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $2.7 billion in Q2 2025 and bottomed at $1.8 billion in Q1 2026.
• The 3-year median for Long-Term Deferred Tax is $2.2 billion (2024), against an average of $2.2 billion.
• The widest annual swing landed in 2025, when Long-Term Deferred Tax fell 17.41%; it then slumped 31.3% in 2026.
• A 3-year view of Long-Term Deferred Tax shows it stood at $2.4 billion in 2024, then slipped by 17.41% to $2.0 billion in 2025, then retreated by 10.03% to $1.8 billion in 2026.
• The last three Long-Term Deferred Tax figures came in at $1.8 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.

Peer Comparison